Tech Mahindra has joined the BT Life Sciences partner ecosystem to conduct concept trials to pharmaceuticals, contract research organizations, government health organizations, and healthcare providers in the UK, the US, Western Europe, India and Asia Pacific territories.
Ovum says the life sciences industry will spend $40.8 billion by 2017 on IT in the areas of clinical trials, supply chain, business intelligence and analytics.
Life Sciences customers will benefit from specific Tech Mahindra and BT products and services via joint go-to-market activities. For this purpose, Tech Mahindra’s Life Sciences practice capabilities will be aligned with the existing BT for Life Sciences services.
BT Cloud Compute platform enables scientists to create global project groups and collaborate using social media tools, allowing them to upload documents, share results and communicate via IM, voice, video, or chat. In addition, they can analyze results in an environment that segments data and uses qualified hardware components and workflows specific to the pharmaceutical industry.
